Congress
$1,001–$15,000
Traded Aug 7, 2025 · disclosed 26 days later
3 different filers disclosed VRTX within 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
74 tracked managers disclosed the same change for Q2 2025. From a 13F filed Aug 14, 2025 covering holdings at Jun 30, 2025 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q1 2025 13F
209,906
52,372
−75.0%
Share count drives classification; reported value also moves with price
0.18%
Within the filing's reported positions, not the manager's total assets
74
For Q2 2025
Congress
Traded Aug 7, 2025 · disclosed 26 days later
3 different filers disclosed VRTX within 90 days.
Sangeeta N. Bhatia (Director) sold ~$103K of Vertex Pharmaceuticals
Planned saleFund moves
63 tracked managers disclosed the same change for Q2 2025. From a 13F filed Aug 14, 2025 covering holdings at Jun 30, 2025 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.